{"id":17048,"date":"2026-01-11T22:33:52","date_gmt":"2026-01-11T13:33:52","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-2395\/"},"modified":"2026-08-23T12:47:32","modified_gmt":"2026-08-23T03:47:32","slug":"company-2395","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-2395\/","title":{"rendered":"SHIN NIPPON BIOMEDICAL LABORATO"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"2395","DATE":"2026-01-09","longName":"Shin Nippon Biomedical Laboratories, Ltd.","company_name_ja":"","fullTimeEmployees":1680,"address":"","phone":"","website":"https:\/\/www.snbl.co.jp","industry":"Diagnostics & Research","sector":"Healthcare","regularMarketPrice":1643,"financialCurrency":"","marketCap":68401,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":109.69,"epsForward":0,"bookValue":0,"totalRevenue":32524960000,"OperatingIncome":2653913000,"operatingMargins":8.1600000000000001,"NetIncome":4566696000,"profitMargins":14.039999999999999,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":10.59,"recommendationMean":2,"recommendationKey":"buy","targetMeanPrice":2340,"numberOfAnalystOpinions":2,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-06-01T05:05:08.497842\", \"ticker\": \"2395\", \"ticker_full\": \"2395.T\", \"company_name\": \"SHIN NIPPON BIOMEDICAL LABORATO\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"3\", \"strong_buy\": 1, \"buy\": 1, \"hold\": 0, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 2, \"recommendation_key\": \"buy\", \"recommendation_mean\": 2.0}, \"target_prices\": {\"has_data\": true, \"current\": 1103.0, \"high\": 3400.0, \"low\": 1280.0, \"mean\": 2340.0, \"median\": 2340.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": null, \"future_count\": 0, \"past_earnings\": [{\"date\": \"2025-02-04\", \"eps_estimate\": 21.8, \"eps_actual\": 45.02, \"surprise_pct\": 106.51}, {\"date\": \"2024-08-05\", \"eps_estimate\": 24.97, \"eps_actual\": 2.93, \"surprise_pct\": -88.27}, {\"date\": \"2024-02-01\", \"eps_estimate\": 41.02, \"eps_actual\": 19.9, \"surprise_pct\": -51.49}, {\"date\": \"2023-11-07\", \"eps_estimate\": 26.97, \"eps_actual\": 38.26, \"surprise_pct\": 41.86}, {\"date\": \"2023-08-01\", \"eps_estimate\": 20.29, \"eps_actual\": 32.98, \"surprise_pct\": 62.54}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 51.77, \"institution_pct\": 23.79, \"major_holders\": [{\"label\": \"\", \"value\": 51.77}, {\"label\": \"\", \"value\": 23.79}, {\"label\": \"\", \"value\": 49.33}, {\"label\": \"\", \"value\": 39.0}], \"institutional_holders\": [{\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 280604, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.67, \"pct_change\": 6.85, \"value\": 309506212}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 187921, \"date_reported\": \"2025-12-31\", \"pct_held\": 0.45, \"pct_change\": 11.31, \"value\": 207276863}, {\"holder\": \"WisdomTree Trust-WisdomTree Japan Hedged Equity Fund\", \"shares\": 141000, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.34, \"pct_change\": 0.43, \"value\": 155523000}, {\"holder\": \"VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap \", \"shares\": 71000, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.17, \"pct_change\": -5.33, \"value\": 78313000}, {\"holder\": \"SCHWAB STRATEGIC TRUST-Schwab International Small-Cap Equity ETF\", \"shares\": 46332, \"date_reported\": \"2026-02-28\", \"pct_held\": 0.11, \"pct_change\": -1.15, \"value\": 51104196}, {\"holder\": \"VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Pacific Stock Index Fd.\", \"shares\": 25110, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.06, \"pct_change\": 8.19, \"value\": 27696330}, {\"holder\": \"WisdomTree Trust-WisdomTree Japan SmallCap Dividend Fund\", \"shares\": 20700, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.05, \"pct_change\": -5.48, \"value\": 22832100}, {\"holder\": \"Dimensional ETF Trust-Dimensional International Small Cap ETF\", \"shares\": 17300, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.04, \"pct_change\": 0.0, \"value\": 19081900}, {\"holder\": \"American Century ETF Trust-Avantis International Small Cap Value ETF\", \"shares\": 15400, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.04, \"pct_change\": 0.0, \"value\": 16986200}, {\"holder\": \"WisdomTree Trust-WisdomTree Dynamic International Equity Fund\", \"shares\": 15200, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.04, \"pct_change\": 94.87, \"value\": 16765600}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":30,"get_dividend_history_year2":50,"get_dividend_history_year3":50,"get_dividend_history_year4":50,"get_dividend_history_year5":60,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:41:12.842310\", \"ticker\": \"2395\", \"ticker_full\": \"2395.T\", \"company_name\": \"SHIN NIPPON BIOMEDICAL LABORATO\", \"company_info\": {\"name_en\": \"SHIN NIPPON BIOMEDICAL LABORATO\", \"long_name\": \"Shin Nippon Biomedical Laboratories, Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Diagnostics & Research\", \"website\": \"https:\/\/www.snbl.co.jp\", \"employees\": 1680, \"country\": \"Japan\", \"city\": \"Kagoshima\", \"address\": \"2438 Miyanoura-cho\", \"description\": \"Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 1457.2, \"deviation\": -2.69, \"trend\": \"down\"}, \"ma_25\": {\"ma_value\": 1370.76, \"deviation\": 3.45, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 1245.03, \"deviation\": 13.89, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 1459.31, \"deviation\": -2.83, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 32524960000.0, \"revenue_fmt\": \"\u00a5325\u5104\", \"gross_profit\": 16238747000.0, \"gross_profit_fmt\": \"\u00a5162\u5104\", \"operating_income\": 2653913000.0, \"operating_income_fmt\": \"\u00a527\u5104\", \"ebit\": 6540736000.0, \"ebit_fmt\": \"\u00a565\u5104\", \"net_income\": 4566696000.0, \"net_income_fmt\": \"\u00a546\u5104\", \"eps\": 109.69, \"operating_margin\": 8.16, \"total_assets\": 105055514000.0, \"total_assets_fmt\": \"\u00a51051\u5104\", \"total_equity\": 43120756000.0, \"total_equity_fmt\": \"\u00a5431\u5104\", \"total_debt\": 41259141000.0, \"total_debt_fmt\": \"\u00a5413\u5104\", \"total_cash\": 18536325000.0, \"total_cash_fmt\": \"\u00a5185\u5104\", \"equity_ratio\": 41.05, \"de_ratio\": 0.96, \"current_ratio\": 1.09, \"operating_cf\": 8327022000.0, \"operating_cf_fmt\": \"\u00a583\u5104\", \"investing_cf\": -6790775000.0, \"investing_cf_fmt\": \"-\u00a568\u5104\", \"financing_cf\": 4514155000.0, \"financing_cf_fmt\": \"\u00a545\u5104\", \"free_cf\": 2990908000.0, \"free_cf_fmt\": \"\u00a530\u5104\", \"net_margin\": 14.04, \"roe\": 10.59, \"roa\": 4.35}, {\"year\": 2025, \"revenue\": 32413807000.0, \"revenue_fmt\": \"\u00a5324\u5104\", \"gross_profit\": 16960947000.0, \"gross_profit_fmt\": \"\u00a5170\u5104\", \"operating_income\": 2985223000.0, \"operating_income_fmt\": \"\u00a530\u5104\", \"ebit\": 6215844000.0, \"ebit_fmt\": \"\u00a562\u5104\", \"net_income\": 4924848000.0, \"net_income_fmt\": \"\u00a549\u5104\", \"eps\": 118.29, \"operating_margin\": 9.21, \"total_assets\": 92416508000.0, \"total_assets_fmt\": \"\u00a5924\u5104\", \"total_equity\": 40022734000.0, \"total_equity_fmt\": \"\u00a5400\u5104\", \"total_debt\": 34474036000.0, \"total_debt_fmt\": \"\u00a5345\u5104\", \"total_cash\": 12032136000.0, \"total_cash_fmt\": \"\u00a5120\u5104\", \"equity_ratio\": 43.31, \"de_ratio\": 0.86, \"current_ratio\": 1.13, \"operating_cf\": 7035243000.0, \"operating_cf_fmt\": \"\u00a570\u5104\", \"investing_cf\": -11691221000.0, \"investing_cf_fmt\": \"-\u00a5117\u5104\", \"financing_cf\": 5914147000.0, \"financing_cf_fmt\": \"\u00a559\u5104\", \"free_cf\": -3897492000.0, \"free_cf_fmt\": \"-\u00a539\u5104\", \"net_margin\": 15.19, \"roe\": 12.31, \"roa\": 5.33}, {\"year\": 2024, \"revenue\": 26450468000.0, \"revenue_fmt\": \"\u00a5265\u5104\", \"gross_profit\": 14282576000.0, \"gross_profit_fmt\": \"\u00a5143\u5104\", \"operating_income\": 4162365000.0, \"operating_income_fmt\": \"\u00a542\u5104\", \"ebit\": 7113227000.0, \"ebit_fmt\": \"\u00a571\u5104\", \"net_income\": 5531261000.0, \"net_income_fmt\": \"\u00a555\u5104\", \"eps\": 132.86, \"operating_margin\": 15.74, \"total_assets\": 76302347000.0, \"total_assets_fmt\": \"\u00a5763\u5104\", \"total_equity\": 34114417000.0, \"total_equity_fmt\": \"\u00a5341\u5104\", \"total_debt\": 26186858000.0, \"total_debt_fmt\": \"\u00a5262\u5104\", \"total_cash\": 10274773000.0, \"total_cash_fmt\": \"\u00a5103\u5104\", \"equity_ratio\": 44.71, \"de_ratio\": 0.77, \"current_ratio\": 1.31, \"operating_cf\": 2106732000.0, \"operating_cf_fmt\": \"\u00a521\u5104\", \"investing_cf\": -6907735000.0, \"investing_cf_fmt\": \"-\u00a569\u5104\", \"financing_cf\": 5318656000.0, \"financing_cf_fmt\": \"\u00a553\u5104\", \"free_cf\": -6498514000.0, \"free_cf_fmt\": \"-\u00a565\u5104\", \"net_margin\": 20.91, \"roe\": 16.21, \"roa\": 7.25}, {\"year\": 2023, \"revenue\": 25090903000.0, \"revenue_fmt\": \"\u00a5251\u5104\", \"gross_profit\": 13046668000.0, \"gross_profit_fmt\": \"\u00a5130\u5104\", \"operating_income\": 5245242000.0, \"operating_income_fmt\": \"\u00a552\u5104\", \"ebit\": 7884672000.0, \"ebit_fmt\": \"\u00a579\u5104\", \"net_income\": 6060057000.0, \"net_income_fmt\": \"\u00a561\u5104\", \"eps\": 145.56, \"operating_margin\": 20.9, \"total_assets\": 57242205000.0, \"total_assets_fmt\": \"\u00a5572\u5104\", \"total_equity\": 26211832000.0, \"total_equity_fmt\": \"\u00a5262\u5104\", \"total_debt\": 18760662000.0, \"total_debt_fmt\": \"\u00a5188\u5104\", \"total_cash\": 10533094000.0, \"total_cash_fmt\": \"\u00a5105\u5104\", \"equity_ratio\": 45.79, \"de_ratio\": 0.72, \"current_ratio\": 1.14, \"operating_cf\": 4004019000.0, \"operating_cf_fmt\": \"\u00a540\u5104\", \"investing_cf\": -5930578000.0, \"investing_cf_fmt\": \"-\u00a559\u5104\", \"financing_cf\": 6266243000.0, \"financing_cf_fmt\": \"\u00a563\u5104\", \"free_cf\": -951696000.0, \"free_cf_fmt\": \"-\u00a510\u5104\", \"net_margin\": 24.15, \"roe\": 23.12, \"roa\": 10.59}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 60.0}, {\"year\": 2023, \"amount\": 50.0}, {\"year\": 2024, \"amount\": 50.0}, {\"year\": 2025, \"amount\": 50.0}, {\"year\": 2026, \"amount\": 30.0}], \"latest\": 30.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-17048","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SHIN NIPPON BIOMEDICAL LABORATO - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-2395\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2395\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-2395\/\",\"name\":\"SHIN NIPPON BIOMEDICAL LABORATO - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-01-11T13:33:52+00:00\",\"dateModified\":\"2026-08-23T03:47:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2395\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-2395\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2395\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHIN NIPPON BIOMEDICAL LABORATO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHIN NIPPON BIOMEDICAL LABORATO - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-2395\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-2395\/","url":"https:\/\/japanir.jp\/en\/company\/company-2395\/","name":"SHIN NIPPON BIOMEDICAL LABORATO - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-01-11T13:33:52+00:00","dateModified":"2026-08-23T03:47:32+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-2395\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-2395\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-2395\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"SHIN NIPPON BIOMEDICAL LABORATO"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/17048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=17048"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=17048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}